Lv52
1540 积分 2021-08-17 加入
Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts
14小时前
待确认
Targeting ADAR1 with a Novel Small-Molecule for the Treatment of Prostate Cancer
28天前
已完结
PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer
1个月前
已完结
Targeting USP8 causes synthetic lethality through degradation of FGFR2 in ARID1A-deficient ovarian clear cell carcinoma
1个月前
已完结
Collateral lethality: A unique type of synthetic lethality in cancers
1个月前
已完结
Synthetic lethal strategies for the development of cancer therapeutics
1个月前
已完结
Discovery of FHD-286, a First-in-Class, Orally Bioavailable, Allosteric Dual Inhibitor of the Brahma Homologue (BRM) and Brahma-Related Gene 1 (BRG1) ATPase Activity for the Treatment of SWItch/Sucrose Non-Fermentable (SWI/SNF) Dependent Cancers
2个月前
已完结
PROTAC cell permeability and oral bioavailability: a journey into uncharted territory
3个月前
已完结
Targeting the E3 ubiquitin ligases DCAF15 and cereblon for cancer therapy
3个月前
已完结
SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion
3个月前
已完结
皖公网安备34019202002308
